RecruitingNot ApplicableNCT06373289

Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants

Target Oxygen Saturation Ranges in Infants With Bronchopulmonary Dysplasia Associated Pulmonary Hypertension

Sponsor

University of Alabama at Birmingham

Enrollment

39 participants

Start Date

Sep 15, 2026

Study Type

INTERVENTIONAL

Conditions

Pulmonary Hypertension Bronchopulmonary Dysplasia

Summary

Around 50% of infants born extremely preterm develop a chronic lung disease known as bronchopulmonary dysplasia of which some infants will also develop pulmonary hypertension of which 50% of children will die before the age of 2. Physicians are currently limited in their ability to select the most appropriate oxygen targets that will improve outcomes in infants with this condition. This clinical trial will determine whether using different amounts of oxygen improve outcomes in infants with this disease.

Eligibility

Min Age: 1 MonthMax Age: 5 Months

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called higher oxygen saturation target using Nellcor pulse oximetry sensors and a medical device called lower oxygen saturation target using Nellcor pulse oximetry sensors for people with bronchopulmonary dysplasia and pulmonary hypertension. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 1 Month to 5 Months.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.